Business
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference
Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, patient stratification, and future therapeutic development. POTOMAC, MD / ACCESS Newswire / May 15, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or ...
About this update from Igc Pharma, Inc.
[{"type":"text","content":"Research highlights advanced imaging analytics that may support Alzheimer's disease monitoring, patient stratification, and future therapeutic development.","length":159,"tagName":"p"},{"type":"text","content":"POTOMAC, MD / ACCESS Newswire / May 15, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, today announced that it will present new Tau-PET biomarker research at the 2026 Global Tau Conference, taking place May 14-15, 2026, at the Grand Hyatt Washington in Washington, D.C., and online.","length":417,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"IGC Pharma, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1504,"height":890,"url":"https://media.zenfs.com/en/accesswire.ca/e71d1130dfca6fa7cd6d48978ef188b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6aSHjMYFEDO0oFlgkc93zw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU2OA--/https://media.zenfs.com/en/accesswire.ca/e71d1130dfca6fa7cd6d48978ef188b1","width":960,"height":568},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/be1l7kjshtdmzRYzXgDy8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM3OQ--/https://media.zenfs.com/en/accesswire.ca/e71d1130dfca6fa7cd6d48978ef188b1","width":640,"height":379},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/CYvnKESiHR19Zqe1F4Zrng--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNDIw/https://media.zenfs.com/en/accesswire.ca/e71d1130dfca6fa7cd6d48978ef188b1","width":1200,"height":710}},"href":"https://app.accessnewswire.com/imagelibrary/d8eb3517-f4c2-4ee4-bec0-a6a281e1591c/igc-pharma-inc-2026.png","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The poster presentation, titled "Shannon Entropy of Tau-PET Spreading Patterns Predict Alzheimer's Disease Progression in Amyloid-Positive APOE4 Carriers," evaluates whether Shannon entropy can serve as a quantitative measure of spatial heterogeneity in tau pathology, a key feature of Alzheimer's disease progression.","length":336,"tagName":"p"},{"type":"text","content":"The analysis utilized F-AV-1451 Tau-PET imaging data from 931 participants and 1,570 scans obtained through the Alzheimer's Disease Neuroimaging Initiative (ADNI). The team assessed whether tau distrib...